SCHEMBL27157150

SCHEMBL27157150

NC(=O)c1coc2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 10/20 0.68
▸ ALDH1A1 P00352 8/20 0.68
▸ KMT2A Q03164 8/20 0.68
▸ MEN1 O00255 7/20 0.68
▸ HTT P42858 4/20 0.68
▸ NPSR1 Q6W5P4 4/20 0.68
▸ MAPK1 P28482 4/20 0.68
▸ TDP1 Q9NUW8 3/20 0.68
▸ APAF1 O14727 2/20 0.68
▸ CASP3 P42574 1/20 0.68
▸ SENP8 Q96LD8 1/20 0.68
▸ SENP7 Q9BQF6 1/20 0.68
▸ SENP6 Q9GZR1 1/20 0.68
▸ KDM4E B2RXH2 4/20 0.55
▸ LMNA P02545 4/20 0.55
▸ HPGD P15428 3/20 0.55
▸ HKDC1 Q2TB90 2/20 0.55
▸ CDC25A P30304 1/20 0.55
▸ CDC25B P30305 1/20 0.55
▸ CDC25C P30307 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29892465 1.00 MAPT (0.68) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL29362140 0.83 MAPT (0.68) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL14657071 0.83 MAPT (0.68) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL25649956 0.75 ADORA2A (0.55) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL16167389 0.72 NQO1 (0.53) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL30601020 0.72 MAPT (0.53) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL7121384 0.72 KEAP1 (0.86) MAPTALDH1A1KMT2AMEN1NPSR1
SCHEMBL7829487 0.72 KEAP1 (0.73) MAPTALDH1A1HTTLMNAKEAP1
SCHEMBL16167167 0.72 MAPT (0.53) MAPTALDH1A1KMT2AMEN1HTT
SCHEMBL801214 0.71 MAPT (1.00) MAPTALDH1A1KMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11919886-B2 4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases ACADEMIA SINICA (TW) 2024-03-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11919886-B2 4,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases DHODH, NQO2, PKD1 MAPT 4228/4885ALDH1A1 199/4885KMT2A 2900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback